We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
25 hedge funds and large institutions have $26.4M invested in Cardiff Oncology in 2013 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
489% more capital invested
Capital invested by funds: $4.49M → $26.4M (+$21.9M)
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
56% more funds holding
Funds holding: 16 → 25 (+9)
Holders
25
Holders Change
+9
Holders Change %
+56.25%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
8
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BM
Bridger Management
New York
|
+$16.9M |
| 2 |
Morgan Stanley
New York
|
+$2.29M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.05M |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$1.02M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$643K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -1 | Closed |
|
|
SSG
27
Summit Securities Group
New York
| – | +$569 | +1 | New |
|